鳐血管生成抑制因子1可用于制备抑制血管生成和防治肿瘤的药物。
The sea purse angiogenesis inhibitive factor 1 can be used to prepare drugs inhibiting the angiogenesis and preventing tumors.
血管生成促进因子和血管生成抑制因子的平衡控制着肿瘤新生血管的形成。
Formation of tumor new vessels is controlled by balances between angiogenic stimulators and inhibitors.
目的研究血管生成抑制因子su 5416对结肠癌生长和转移的抑制作用。
Objective to study the effects of angiogenesis inhibitor SU5416on the growth and metastasis of colon cancer in vivo.
近年来，研究发现了多种内源性血管生成抑制因子，其中一些已进入了临床试验阶段。
Recently, many endogenous angiogenesis inhibitors have been discovered, some of them are currently in various stages of clinical trials.
结果表明，紫杉醇对血管生成有很强的抑制效应，证实紫杉醇是一种血管生成抑制因子。
The results showed that paclitaxel has inhibitory effect on angiogenesis strongly, it is a specific angiogenesis angiogenesis inhibiting factor.
本文对内源性血管生成抑制因子的结构、功能、作用机制及其在肿瘤治疗中的应用进行综述。
This review focused on the structure, function, and mechanism of endogenous angiogenesis inhibitors, and their potential in treating tumor.
目的探讨脑组织特异性血管生成抑制因子1 (BAI1)对胶质母细胞瘤的治疗作用及其作用机制。
Objective to study the therapeutic effects of brain-specific angiogenesis inhibitor 1 (BAI1) on human glioblastoma and relevant mechanism.
她说这也就可以解释为什么试图通过血管生成抑制因子来阻断血管生长信号而阻断肿瘤血液供应的药物通常在六周内失去作用。
She says that this could explain why cancer drugs aimed at choking off a tumor's blood supply by blocking growth signals, known as angiogenesis inhibitors, usually stop working within about 6 months.
目的：研究人骨肉瘤OS 732细胞系促血管生成作用及血管内皮生长因子（VEGF）抗体对其血管生成的抑制作用。
Purpose To study the angiogenesis induced by OS 732 cell line and its inhibition by anti VEGF antibody.
以血管内皮生长因子(VEGF)通路为靶点，抑制肾细胞癌血管生成，已成为肾细胞癌治疗的研究热点。
Therapy targeting for vascular endothelial growth factor (VEGF) signaling can inhibit angiogenesis of RCC, which is one of hot issues in RCC management.
目的探讨直肠癌组织中脑特异性血管生长抑制因子1 (BAI1)基因的表达情况及BAI1对肿瘤血管生成和肿瘤生长的作用。
Objective to explore the expression of brain-specific angiogenesis inhibitor 1 (BAI1) gene in rectal cancer tissues and its effect on growth and angiogenesis of the tumor.
肿瘤血管生成是肿瘤生长转移的关键步骤，是促血管生成因子和抑制因子作用失衡的结果。
Tumor angiogenesis, resulting from the imbalance of angiogenic cytokines and angiogenesis inhibitors, is crucial for tumor growth and metastasis.
内皮抑素是一种抗血管生成的抑制因子，它特异性地作用于新生微血管的内皮细胞，其水平与肿瘤血管生成有着明显的相关性。
Endostatin is a kind of angiogenesis inhibitor, specific effecting in the new microvascular endothelial cells. The level of endostatin and the angiogenesis of tumor have a close correlation.
结论：血管皮生长因子通过启动血管生成而促进肿瘤的生长，阻断血管内皮生长因子的产生可以抑制肿瘤的生长。
Conclusion: As starting angiogenesis, VEGF might promote the growth of tumor, and the inhibition of VEGF production might prevent solid tumor from growing.
其中用于提高耐力的主要有促红细胞生成素、血管内皮生长因子等，用于提高肌肉力量的有胰岛素样生长因子-I、肌肉生长抑制素、生长激素、机械生长因子等。
In those gene doping, EPO and VEGF are used to enhance the endurance performance; IGF-I, myostatin, GH and MGF are used to improve muscle strength.
肿瘤血管生成是个多步骤的过程，众多肿瘤血管生成生长因子和抑制因子参与了对肿瘤血管生成的调控。
Blood vessel producing of tumor is a multi-steps procession. Various pro - and anti-factors in blood vessel producing of tumor take part in regulation of blood vessel producing of tumor.
大多数血管生成因子在刺激血管ec增殖和迁移的同时抑制血管EC凋亡。
Most angiogenic growth factors not only stimulate VEC proliferation and migration but concomitantly inhibit VEC apoptosis.
大多数血管生成因子在刺激血管ec增殖和迁移的同时抑制血管EC凋亡。
Most angiogenic growth factors not only stimulate VEC proliferation and migration but concomitantly inhibit VEC apoptosis.
应用推荐